Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation. - Wikidata - wikimedia - TriplyDB

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

http://www.wikidata.org/entity/Q38213539

about

New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.Lymphatic imaging: focus on imaging probes.Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology.Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides.A Dual Reporter Iodinated Labeling Reagent for Cancer Positron Emission Tomography Imaging and Fluorescence-guided Surgery.64 CuS-labeled nanoparticles: a new sentinel-lymph-node-mapping agent for PET-CT and photoacoustic tomography.Advancing theranostics with tumor-targeting peptides for precision otolaryngology.NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.Multimodal Molecular Imaging: Current Status and Future Directions.

P2860

Q28274697-84DEC675-BF04-48E9-B069-BC8BF6190B5B Q33827092-4567816D-5CCD-4514-929F-D918E863ACF2 Q34009539-172080B8-D3D9-4139-B6A4-170A0F9FEA52 Q35475925-3FA43B21-357A-497B-9ED2-BBC9327A91DF Q37120903-C3646B71-9694-4590-9D85-BE6DE8DEBA87 Q38752324-165B3A80-729F-485C-9D18-367D7B8A1349 Q42204570-605F356B-E1F7-4055-99A7-2802D4E47325 Q48125631-EBA17841-A598-4826-87D1-2048FCB0AD9E Q52977002-6BF6564C-3A83-46D8-96AF-86E4838182A4 Q55006457-E500A4F6-DAAB-4C0E-BB8D-7BDD20097DB7 Q55170037-2A3CBE3E-8F03-4400-96E2-0E9273BE9DEB Q55416268-7821C9DD-B4A8-414D-995F-428C03F7869E

P2860

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

http://www.wikidata.org/entity/Q38213539

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeted radionuclide and fluo ...... nces and clinical translation.

@en

type

label

Targeted radionuclide and fluo ...... nces and clinical translation.

@en

prefLabel

Targeted radionuclide and fluo ...... nces and clinical translation.

@en

P1433

Q38213539-FB97E8C9-A1DB-43B4-A9BC-519A83EC3924

P1476

Q38213539-DE9F9BB9-1920-4A40-A443-170583DFAE67

P2093

Q38213539-36EEBCE3-8072-4DCB-ACFA-65760F647213

Q38213539-42AA01E4-9119-4DD2-BA61-058045DFCF39

Q38213539-489616FB-CE83-439C-BD28-C5D8AB5FFB4A

Q38213539-5B4DA664-05D4-4875-A120-C873A0D081ED

P2860

Q38213539-008B8B10-ACD8-4D3E-B189-1201F34E906E

Q38213539-0106C197-085C-46BC-9B76-C3787A1DF4C8

Q38213539-034684CF-4592-426E-88D6-0D4677E9C7B1

Q38213539-086B83BB-C5A8-46BC-AFBD-88E7D62AC029

Q38213539-1149E244-D169-4885-91DE-70FB1B7FE0A9

Q38213539-12C1A3BB-DD55-4C93-B2E2-9AEADFD2BD7D

Q38213539-1F975D81-30AD-4BB8-A5D0-7B87A2ACFDA2

Q38213539-20CA8BC0-F1A8-4BAA-8CC0-66E62E9DAC0D

Q38213539-24449CAB-7598-43E8-996B-4E50E00C38B9

Q38213539-247FAF32-80B3-436A-B1F9-D66940068A22

P2888

Q38213539-6C18C337-13FE-4D88-8D88-9FCF83F17399

P304

Q38213539-A35D47DF-6089-49E5-9D60-8175D7BE5D19

P31

Q38213539-3C322EA5-4385-4743-ACEC-70627FF3DD9A

P356

Q38213539-C77DCE4A-1399-472A-A261-601ADFE25CB1

P433

Q38213539-9020CAEB-81B9-443B-B7B3-5B7F1F67CD07

P478

Q38213539-E8BF68D6-7600-4B22-9FA8-21F3930DCC42

P50

Q38213539-9168AF56-C857-4798-9238-59A4A93F5C7F

P577

Q38213539-10DAD026-FC21-4020-BC1E-C1AA61FC7502

P698

Q38213539-8A508E6C-3844-4B68-8F77-276736B10BDE

P356

S11307-014-0747-Y

P1433

Molecular Imaging and Biology

P1476

Targeted radionuclide and fluo ...... ances and clinical translation

@en

P2093

M Rijpkema

http://www.w3.org/2001/XMLSchema#string

O C Boerman

http://www.w3.org/2001/XMLSchema#string

S Lütje

http://www.w3.org/2001/XMLSchema#string

W Helfrich

http://www.w3.org/2001/XMLSchema#string

P2860

A comprehensive overview of radioguided surgery using gamma detection probe technology

Global cancer statistics

Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.

Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.

Low power, biologically benign NIR light triggers polymer disassembly.

Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent

Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets.

Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer

The progress and promise of molecular imaging probes in oncologic drug development.

P2888

s11307-014-0747-y

P304

747-755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11307-014-0747-Y

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24849133

http://www.w3.org/2001/XMLSchema#string